(19)
(11) EP 1 190 061 A1

(12)

(43) Date of publication:
27.03.2002 Bulletin 2002/13

(21) Application number: 00941246.1

(22) Date of filing: 05.06.2000
(51) International Patent Classification (IPC)7C12N 15/31, C12N 15/13, C12N 15/62, C12N 15/72, C12N 1/21, C07K 14/36, C07K 16/28, A61K 39/395, A61K 47/48
(86) International application number:
PCT/US0015/595
(87) International publication number:
WO 0075/333 (14.12.2000 Gazette 2000/50)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.06.1999 US 137900 P
03.12.1999 US 168976 P

(71) Applicant: NEORX CORPORATION
SeattleWashington 98119 (US)

(72) Inventors:
  • GOSHORN, Stephen, Charles
    Shoreline, WA 98177 (US)
  • GRAVES, Scott, Stoll
    Monroe, WA 98272 (US)
  • SCHULTZ, Joanne, Elaine
    Seattle, WA 98112 (US)
  • LIN, Yukang
    Kenmore, WA 98028 (US)
  • SANDERSON, James, Allen
    Seattle, WA 98125 (US)
  • RENO, John, M.
    Brier, WA 98036 (US)

(74) Representative: Gowshall, Jonathan Vallance 
FORRESTER & BOEHMERTPettenkoferstrasse 20-22
80336 München
80336 München (DE)

   


(54) STREPTAVIDIN EXPRESSED GENE FUSIONS AND METHODS OF USE THEREOF